Imperial Innovations Group Regulatory News (IVO)

21 Dec 2006 12:13

Imperial Innovations Group plc21 December 2006 Imperial Innovations Group plc ("Imperial Innovations" or "The Company") Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6,Imperial Innovations (AIM:IVO) is required to notify the market of thefollowing: The capital of Imperial Innovations includes 49,522,205 ordinary shares withvoting rights. None of these ordinary shares are held in Treasury. Therefore, the total number of voting rights in Imperial Innovations is49,522,205. The above figure of 49,522,205 shares may be used by shareholders as thedenominator for the calculations by which they will determine if they arerequired to notify their interest in, or a change to their interest in, theCompany under the FSA's Disclosure and Transparency Rules. -Ends- For more information contact: Imperial Innovations Justin Bowen, Company Secretary +44 (0)20 7594 6593 About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £26 million. The company's integrated approach encompassesthe identification of ideas, protection of intellectual property, developmentand licensing of technology and formation, incubation and investment intechnology businesses. A wide range of technologies are commercialised withinthe areas of healthcare, energy, environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in66 technology businesses and has completed 90 commercial agreements. ImperialInnovations also commercialises technologies originating from outside ImperialCollege through incubation contracts with the Carbon Trust and WRAP and hasrelationships with a number of multinational corporations including BAE Systems. Imperial Innovations has invested in a range of spin-out companies, includingThe Acrobot Company Limited, Cardiak Limited, deltaDOT Limited, Future Waves PTELimited, HeliSwirl Technologies Limited, InforSense Limited, Lontra Limited,Midaz Lasers Limited, NanoBioDesign Limited, Nexeon Limited, NovaThera Limited,Thiakis Limited and Veryan Medical Limited. Imperial Innovations currently holds shares in four technology businesses nowlisted on AIM including the fuel cell company, Ceres Power plc. This information is provided by RNS The company news service from the London Stock Exchange